Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew M Blumenfeld

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Journal of Primary Care & Community Health|September 29, 2020
Clinician-Patient Dialogue About Preventive Chronic Migraine TreatmentAndrew M Blumenfeld
Headache|June 27, 2023
Injection technique of the upper face with onabotulinumtoxinA in chronic migraineMagdalena Boczarska-Jedynak, Andrew M Blumenfeld
BMC Neurology|March 5, 2022
Adjunctive treatment of chronic migraine using an oral dental device: overview and results of a randomized placebo-controlled crossover studyAndrew M Blumenfeld, James P Boyd
Dermatologic Clinics|June 30, 2004
Botulinum neurotoxin for the treatment of migraine and other primary headache disordersAndrew M Blumenfeld, David W Dodick, Stephen D Silberstein
Headache|December 1, 2007
Botulinum toxin type A and divalproex sodium for prophylactic treatment of episodic or chronic migraineAndrew M Blumenfeld, Jack D Schim, Thomas J Chippendale
BMC Neurology|July 3, 2015
Unmet clinical needs in chronic migraine: Rationale for study and design of COMPEL, an open-label, multicenter study of the long-term efficacy, safety, and tolerability of onabotulinumtoxinA for headache prophylaxis in adults with chronic migraineAndrew M Blumenfeld, Sheena K Aurora, Karen Laranjo, et al.
The Journal of Headache and Pain|February 7, 2018
Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL studyAndrew M Blumenfeld, Richard J Stark, Marshall C Freeman, et al.
Headache|July 1, 2020
Mechanism of Action of OnabotulinumtoxinA in Chronic Migraine: A Narrative ReviewRami Burstein, Andrew M Blumenfeld, Stephen D Silberstein, et al.
Pain and Therapy|November 23, 2022
Effectiveness and Safety of Chronic Migraine Preventive Treatments: A Systematic Literature ReviewAndrew M Blumenfeld, Gavneet Kaur, Anadi Mahajan, et al.
Headache|November 13, 2010
A multi-center double-blind pilot comparison of onabotulinumtoxinA and topiramate for the prophylactic treatment of chronic migraineRoger K Cady, Curtis P Schreiber, John A H Porter, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Journal of Primary Care & Community Health|September 29, 2020
Clinician-Patient Dialogue About Preventive Chronic Migraine TreatmentAndrew M Blumenfeld
Headache|June 27, 2023
Injection technique of the upper face with onabotulinumtoxinA in chronic migraineMagdalena Boczarska-Jedynak, Andrew M Blumenfeld
BMC Neurology|March 5, 2022
Adjunctive treatment of chronic migraine using an oral dental device: overview and results of a randomized placebo-controlled crossover studyAndrew M Blumenfeld, James P Boyd
Dermatologic Clinics|June 30, 2004
Botulinum neurotoxin for the treatment of migraine and other primary headache disordersAndrew M Blumenfeld, David W Dodick, Stephen D Silberstein
Headache|December 1, 2007
Botulinum toxin type A and divalproex sodium for prophylactic treatment of episodic or chronic migraineAndrew M Blumenfeld, Jack D Schim, Thomas J Chippendale
BMC Neurology|July 3, 2015
Unmet clinical needs in chronic migraine: Rationale for study and design of COMPEL, an open-label, multicenter study of the long-term efficacy, safety, and tolerability of onabotulinumtoxinA for headache prophylaxis in adults with chronic migraineAndrew M Blumenfeld, Sheena K Aurora, Karen Laranjo, et al.
The Journal of Headache and Pain|February 7, 2018
Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL studyAndrew M Blumenfeld, Richard J Stark, Marshall C Freeman, et al.
Headache|July 1, 2020
Mechanism of Action of OnabotulinumtoxinA in Chronic Migraine: A Narrative ReviewRami Burstein, Andrew M Blumenfeld, Stephen D Silberstein, et al.
Pain and Therapy|November 23, 2022
Effectiveness and Safety of Chronic Migraine Preventive Treatments: A Systematic Literature ReviewAndrew M Blumenfeld, Gavneet Kaur, Anadi Mahajan, et al.
Headache|November 13, 2010
A multi-center double-blind pilot comparison of onabotulinumtoxinA and topiramate for the prophylactic treatment of chronic migraineRoger K Cady, Curtis P Schreiber, John A H Porter, et al.
Pageof 5